Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 6 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 12038433

    Methods and apparatus for high-throughput screening for testing permeability and retention of compounds across biological barriers

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  2. US 12037390

    Leptin antibodies and method of reducing leptin

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  3. US 12036269

    Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  4. US 12036231

    Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  5. US 12036319

    Polyvalent sting activating compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  6. US 12031008

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  7. US 12029816

    Compositions and methods of making brittle-matrix particles through blister pack freezing

    The Board of Regents of the University of Texas System · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  8. US 12024486

    Lipocationic dendrimers and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  9. US 12023343

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  10. US 12013406

    Methods of detecting anti-folic acid antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  11. US 11999778

    VH4 antibodies and compositions comprising the same

    The Board of Regents of the University of Texas System · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  12. US 11999683

    Lipocationic dendrimers and uses thereof

    The Board of Regents of the University of Texas System · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  13. US 11998521

    Use of an RXR agonist in treating drug resistant HER2+ cancers

    The Board of Regents of the University of Texas System · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  14. US 11998606

    Compounds and methods for selective proteolysis of glucocorticoid receptors

    The Board of Regents of the University of Texas System · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  15. US 11986561

    Wound dressings and applications thereof

    The Board of Regents of the University of Texas System · Granted May 21, 2024 · Expires May 16, 2044

    granted
  16. US 11981736

    Antibodies specific to glycosylated PD-1 and methods of use thereof

    The Board of Regents of the University of Texas System · Granted May 14, 2024 · Expires May 9, 2044

    granted
  17. US 11981740

    BAFF-R antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted May 14, 2024 · Expires May 9, 2044

    granted
  18. US 11980634

    Method of reconstituting liposomal annamycin

    The Board of Regents of the University of Texas System · Granted May 14, 2024 · Expires May 9, 2044

    granted
  19. US 11981662

    Pyrazole derivatives with anticancer activity

    The Board of Regents of the University of Texas System · Granted May 14, 2024 · Expires May 9, 2044

    granted
  20. US 11976128

    Human PD-L2 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System · Granted May 7, 2024 · Expires May 2, 2044

    granted
  21. US 11970534

    Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  22. US 11969522

    Use of immune modulators to improve nerve regeneration

    The Board of Regents of the University of Texas System · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  23. US 11969511

    Methods and compositions for antimicrobial treatment

    The Board of Regents of the University of Texas System · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  24. US 11969499

    Hydrogel delivery of sting immunotherapy for treatment cancer

    The Board of Regents of the University of Texas System · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted